Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 16,535 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 16,535 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total value of $271,174.00. Following the completion of the transaction, the president now owns 2,374,051 shares of the company’s stock, valued at $38,934,436.40. This trade represents a 0.69 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $17.19 on Thursday. The business has a 50 day simple moving average of $14.68 and a two-hundred day simple moving average of $12.59. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $17.38. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The stock has a market capitalization of $3.30 billion, a P/E ratio of -22.32 and a beta of 1.49.

Institutional Investors Weigh In On Alignment Healthcare

A number of large investors have recently modified their holdings of the business. R Squared Ltd purchased a new stake in Alignment Healthcare in the 4th quarter valued at $55,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $106,000. Tower Research Capital LLC TRC boosted its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after buying an additional 6,286 shares during the period. Ballentine Partners LLC acquired a new position in Alignment Healthcare during the 4th quarter worth about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Alignment Healthcare in the third quarter valued at approximately $131,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

ALHC has been the topic of several analyst reports. Stifel Nicolaus increased their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Barclays lifted their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Piper Sandler boosted their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Bank of America raised their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research note on Tuesday, March 4th. Finally, William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.